Research Topics
| Catherine B SmithSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
| Collaborators
|
Detail Information
Publications
Experimental evaluation of the FluChip diagnostic microarray for influenza virus surveillanceMichael B Townsend
Department of Chemistry and Biochemistry, UCB 215, University of Colorado, Boulder, CO 80309, USA
J Clin Microbiol 44:2863-71. 2006..In the overwhelming majority of cases in which incomplete subtyping was observed, the failure was due to the nucleic acid amplification step rather than limitations in the microarray...
Molecular epidemiology of influenza A(H3N2) virus reinfectionsCatherine B Smith
Influenza Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 185:980-5. 2002....
Reassortment and evolution of current human influenza A and B virusesXiyan Xu
Influenza Branch, Centers for Disease Control and Prevention, Mail Stop G16, 1600 Clifton Road, NE, Atlanta, GA 30333, USA
Virus Res 103:55-60. 2004..On the other hand, widespread circulation of influenza B Victoria lineage viruses required inclusion of a strain from this lineage in influenza vaccines for the 2002-2003 season...
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humansRebecca J Garten
WHO Collaborating Center for Influenza, Centers for Disease Control and Prevention CDC, Atlanta, GA 30333, USA
Science 325:197-201. 2009..Antigenically the viruses are homogeneous and similar to North American swine A(H1N1) viruses but distinct from seasonal human A(H1N1)...
Antigenic drift in the evolution of H1N1 influenza A viruses resulting from deletion of a single amino acid in the haemagglutinin geneNatalie J McDonald
Influenza Division, Coordinating Centers for Disease Control and Prevention, Atlanta, GA, USA
J Gen Virol 88:3209-13. 2007....
Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwideVarough M Deyde
Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
J Infect Dis 196:249-57. 2007..The results of the study highlight the necessity of close monitoring of resistance to existing antivirals as wells as the need for new therapeutics...
Intercontinental circulation of human influenza A(H1N2) reassortant viruses during the 2001-2002 influenza seasonXiyan Xu
Influenza Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 186:1490-3. 2002....
Evolution of highly pathogenic H5N1 avian influenza viruses in Vietnam between 2001 and 2007Xiu Feng Wan
Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
PLoS ONE 3:e3462. 2008..Although the routes of entry and spread of H5N1 in Vietnam remain speculative, enhanced poultry import controls and virologic surveillance efforts may help curb the entry and spread of new HPAI viral genes...
Robust sequence selection method used to develop the FluChip diagnostic microarray for influenza virusMartin Mehlmann
Department of Chemistry and Biochemistry, University of Colorado, UCB215, Boulder, CO 80303, USA
J Clin Microbiol 44:2857-62. 2006..A detailed experimental evaluation of the selected sequences is described in a companion paper. The software is freely available under the General Public License at http://www.colorado.edu/chemistry/RGHP/software/...
Genetic and antigenic analysis of the first A/New Caledonia/20/99-like H1N1 influenza isolates reported in the AmericasLuke T Daum
Brooks Air Force Base, San Antonio, TX 78235, USA
Emerg Infect Dis 8:408-12. 2002..For the 2000/01 and 2001/02 influenza seasons, the World Health Organization (WHO) has recommended the inclusion of A/New Caledonia/20/99 as the H1N1 vaccine component for both the southern and northern hemispheres...
MChip: a tool for influenza surveillanceErica D Dawson
Department of Chemistry and Biochemistry, UCB 215, University of Colorado at Boulder, Boulder, Colorado 80309, USA
Anal Chem 78:7610-5. 2006..The assay exhibited a clinical sensitivity of 95% and clinical specificity of 92%...
